Stent Grafts Market Size, Share, Trends, Growth Outlook

Stent Grafts Market is estimated to increase at a growth rate of 6.5% CAGR over the forecast period from 2024 to 2030.

The global Stent Grafts Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Coronary Stent Grafts, Peripheral Stent Grafts).

An Introduction to Stent Grafts Market in 2024

The Stent Grafts Market encompasses endovascular devices, vascular implants, and aortic stent graft systems used in interventional cardiology, vascular surgery, and endovascular procedures for treating aortic aneurysms, arterial stenosis, and vascular lesions. Stent grafts provide structural support, reinforce vessel walls, and redirect blood flow, reducing aneurysm expansion, preventing rupture, and restoring blood flow in occluded or narrowed blood vessels. Market trends focus on minimally invasive stent graft procedures, fenestrated stent graft technologies, customized graft designs, and long-term durability of endovascular stent graft implants for vascular disease management.

Stent Grafts Market Competitive Landscape

The global Stent Grafts Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Stent Grafts Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Stent Grafts Industry include- Becton, Dickinson and Company, Cardinal Health Inc, Cook Group Inc, CryoLife Inc, Endologix Inc, Endospan Ltd, Medtronic Plc, MicroPort Scientific Corp, Terumo Corp, W. L. Gore & Associates Inc.

Stent Grafts Market Trend: Endovascular Approach Dominance

A significant trend in the Stent Grafts market is the increasing adoption of endovascular repair techniques over traditional open surgical procedures for the treatment of aortic aneurysms and other vascular diseases. Stent grafts, also known as endovascular stents or endovascular grafts, offer minimally invasive alternatives to open surgery, providing patients with reduced operative morbidity, shorter hospital stays, and faster recovery times. Advances in stent graft design, materials, and delivery systems have enhanced their safety, efficacy, and applicability across a broader range of anatomies and pathologies. Consequently, endovascular stent grafting has become the preferred approach for many vascular surgeons and interventional radiologists, driving market growth and shaping the landscape of vascular intervention.

Stent Grafts Market Driver: Aging Population and Vascular Disease Burden

The primary driver for the Stent Grafts market is the aging population and the increasing prevalence of vascular diseases, particularly aortic aneurysms and peripheral artery disease (PAD). As the global population continues to age, the incidence of age-related vascular conditions rises, leading to a growing demand for effective treatment options to manage these diseases and prevent life-threatening complications such as aortic rupture or limb ischemia. Stent grafts offer a minimally invasive solution for repairing diseased or damaged blood vessels, providing symptomatic relief, preserving limb function, and reducing the risk of adverse cardiovascular events. With the rising burden of vascular disease and the expanding pool of patients eligible for endovascular interventions, there is a sustained demand for stent grafts, driving market expansion and innovation in the field of vascular surgery and interventional radiology.

Stent Grafts Market Opportunity: Technological Advancements and Customization

An opportunity exists in the development of advanced stent graft technologies that offer enhanced performance, durability, and customization to address the diverse anatomical challenges and clinical needs of patients with complex vascular conditions. Innovations in stent graft design, including fenestrated and branched stent grafts, allow for precise anatomical matching and sealing, facilitating the treatment of challenging aortic pathologies such as thoracoabdominal aneurysms and juxtarenal aneurysms. Furthermore, the integration of imaging modalities such as computed tomography angiography (CTA) and three-dimensional (3D) printing enables preoperative planning, patient-specific device selection, and intraoperative navigation, optimizing procedural outcomes and reducing the risk of complications. By investing in research and development efforts focused on next-generation stent graft technologies, manufacturers can capitalize on the growing demand for tailored endovascular solutions, expand their market presence, and improve patient care in the field of vascular surgery.

Stent Grafts Market Share Analysis: Peripheral Stent Grafts is the fastest growing market segment over the forecast period to 2030

Among the segmented categories, Peripheral Stent Grafts emerge as the fast-growing segment in the market for stent grafts. Peripheral stent grafts are increasingly utilized in the treatment of peripheral artery disease (PAD), a condition characterized by the narrowing or blockage of arteries outside the heart, typically in the legs. As the prevalence of PAD rises globally due to factors such as aging populations and lifestyle-related risk factors, there is a growing demand for minimally invasive treatment options to restore blood flow and alleviate symptoms. Peripheral stent grafts offer a less invasive alternative to traditional open surgical procedures, providing physicians with a versatile and effective tool for treating complex arterial lesions and improving patient outcomes. With advancements in stent graft design, materials, and delivery systems, along with expanding indications for peripheral interventions, the market for peripheral stent grafts is expected to experience robust growth in the foreseeable future. Additionally, ongoing research and development efforts focused on enhancing the durability, flexibility, and long-term performance of peripheral stent grafts further underscore their potential as a key driver of growth in the stent grafts market.

Stent Grafts Market Segmentation

By Product
Coronary Stent Grafts
Peripheral Stent Grafts
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Stent Grafts Companies

Becton, Dickinson and Company
Cardinal Health Inc
Cook Group Inc
CryoLife Inc
Endologix Inc
Endospan Ltd
Medtronic Plc
MicroPort Scientific Corp
Terumo Corp
W. L. Gore & Associates Inc
* List not Exhaustive

Reasons to Buy the Stent Grafts Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Stent Grafts Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Stent Grafts Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Stent Grafts Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Stent Grafts Market Size Outlook, $ Million, 2021 to 2030
3.2 Stent Grafts Market Outlook by Type, $ Million, 2021 to 2030
3.3 Stent Grafts Market Outlook by Product, $ Million, 2021 to 2030
3.4 Stent Grafts Market Outlook by Application, $ Million, 2021 to 2030
3.5 Stent Grafts Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Stent Grafts Industry
4.2 Key Market Trends in Stent Grafts Industry
4.3 Potential Opportunities in Stent Grafts Industry
4.4 Key Challenges in Stent Grafts Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Stent Grafts Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Stent Grafts Market Outlook by Segments
7.1 Stent Grafts Market Outlook by Segments, $ Million, 2021- 2030
By Product
Coronary Stent Grafts
Peripheral Stent Grafts
8 North America Stent Grafts Market Analysis and Outlook To 2030
8.1 Introduction to North America Stent Grafts Markets in 2024
8.2 North America Stent Grafts Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Stent Grafts Market size Outlook by Segments, 2021-2030
By Product
Coronary Stent Grafts
Peripheral Stent Grafts
9 Europe Stent Grafts Market Analysis and Outlook To 2030
9.1 Introduction to Europe Stent Grafts Markets in 2024
9.2 Europe Stent Grafts Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Stent Grafts Market Size Outlook by Segments, 2021-2030
By Product
Coronary Stent Grafts
Peripheral Stent Grafts
10 Asia Pacific Stent Grafts Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Stent Grafts Markets in 2024
10.2 Asia Pacific Stent Grafts Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Stent Grafts Market size Outlook by Segments, 2021-2030
By Product
Coronary Stent Grafts
Peripheral Stent Grafts
11 South America Stent Grafts Market Analysis and Outlook To 2030
11.1 Introduction to South America Stent Grafts Markets in 2024
11.2 South America Stent Grafts Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Stent Grafts Market size Outlook by Segments, 2021-2030
By Product
Coronary Stent Grafts
Peripheral Stent Grafts
12 Middle East and Africa Stent Grafts Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Stent Grafts Markets in 2024
12.2 Middle East and Africa Stent Grafts Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Stent Grafts Market size Outlook by Segments, 2021-2030
By Product
Coronary Stent Grafts
Peripheral Stent Grafts
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Becton, Dickinson and Company
Cardinal Health Inc
Cook Group Inc
CryoLife Inc
Endologix Inc
Endospan Ltd
Medtronic Plc
MicroPort Scientific Corp
Terumo Corp
W. L. Gore & Associates Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Coronary Stent Grafts
Peripheral Stent Grafts